Medicine and Dentistry
Allergic Encephalitis
100%
Autoantibodies
14%
Cerebrospinal Fluid
14%
Encephalitis
14%
Epileptic Absence
14%
Immune Checkpoint Blockade
14%
Immune Checkpoint Inhibitor
100%
Immune Response
14%
Immunoglobulin
14%
Immunosuppressive Treatment
42%
Ipilimumab
42%
Malignant Neoplasm
42%
Metastatic Carcinoma
100%
Methylprednisolone
14%
Methylprednisolone Sodium Succinate
14%
N Methyl-D-Aspartate Receptor
14%
Neurologic Disease
14%
Nivolumab
42%
Prednisone
14%
Receptor Antibody
14%
Rituximab
14%
Single Drug Dose
14%
Toxicity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Allergic Encephalitis
100%
Aspartic Acid
14%
Autoantibodies
14%
Encephalitis
14%
Epileptic Absence
14%
Immune Checkpoint Inhibitor
100%
Immunoglobulin
14%
Immunosuppressive Agent
42%
Ipilimumab
42%
Malignant Neoplasm
42%
Metastasis
100%
Methylprednisolone
14%
Methylprednisolone Sodium Succinate
14%
Neurologic Disease
14%
Nivolumab
42%
Prednisone
14%
Receptor Antibody
14%
Rituximab
14%
Toxicity
14%
Immunology and Microbiology
Autoantibodies
14%
Autoimmune Encephalitis
100%
Cerebrospinal Fluid
14%
Encephalitis
14%
Immune Checkpoint Blockade
14%
Immune Response
14%
Immunosuppressive Therapy
42%
Intravenous Immunoglobulin
14%
Ipilimumab
42%
Methylprednisolone
14%
Methylprednisolone Sodium Succinate
14%
Nivolumab
42%
Prednisone
14%
Receptor Antibody
14%
Rituximab
14%
Keyphrases
Paraneoplastic Encephalitis
14%